Stock listing
CRNX Stock Price, News, Filings & Events — Crinetics Pharmaceuticals, Inc.
Selected listing: CRNX · BX · CHF · CH
This page tracks Crinetics Pharmaceuticals, Inc.'s CRNX:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CRNX:BX. CRNX:BX is the stock-level entry point for investors researching Crinetics Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Crinetics Pharmaceuticals, Inc. is a public company traded under the ticker CRNX in the American market. The company has a market capitalization of approximately $8.87 billion. Crinetics focuses on developing innovative therapies for endocrine diseases and disorders.
- Ticker
- CRNX:BX
- Asset type
- Stock
- Market cap
- $9.00B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX
- Currency
- CHF
Crinetics Pharmaceuticals, Inc. CRNX:BX stock context
This page tracks Crinetics Pharmaceuticals, Inc.'s CRNX:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CRNX:BX. CRNX:BX is the stock-level entry point for investors researching Crinetics Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Crinetics Pharmaceuticals, Inc. is a public company traded under the ticker CRNX in the American market. The company has a market capitalization of approximately $8.87 billion. Crinetics focuses on developing innovative therapies for endocrine diseases and disorders.
Latest news from Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 3, 2026
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics...
July 8, 2026
Vertex to Acquire Crinetics Pharmaceuticals
July 6, 2026
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
June 14, 2026
Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities
June 2, 2026
Crinetics Pharmaceuticals, Inc. earnings calls
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Crinetics Pharmaceuticals, Inc. (CRNX) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Research Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for CRNX:BX.
Crinetics Pharmaceuticals, Inc. company profile
View the public company page for Crinetics Pharmaceuticals, Inc. on 6ix.
Crinetics Pharmaceuticals, Inc. news
Read company news and market updates connected to Crinetics Pharmaceuticals, Inc..
Crinetics Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Crinetics Pharmaceuticals, Inc..
Alternate listings
CRNX:NASDAQ
US · USD
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:GETTEX
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
A2JQTJ:LS
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
A2JQTJ:LSX
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:MUN
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
CRNX:BOATS
US · USD
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:TRADEGATE
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:FWB
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:DUS
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:HAM
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.
6Z4:SWB
DE · EUR
Alternate listing for Crinetics Pharmaceuticals, Inc.; the primary context on this page is CRNX:BX.